Temozolomide-induced shrinkage of a pituitary carcinoma causing cushing's disease - Report of a case and literature review

TheScientificWorldJournal

Volumn 10, Issue , 2010, Pages 2132-2138

  Curtò, Lorenzo ^a   Torre, Maria L ^a   Ferraù, Francesco ^a   Pitini, Vincenzo ^a   Altavilla, Giuseppe ^a   Granata, Francesca ^a   Longo, Marcello ^a   Hofland, Leo J ^b   Trimarchi, Francesco ^a   Cannavò, Salvatore ^a  

^a UNIVERSITY OF MESSINA   (Italy)

^b ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Chemotherapy; Cushing's disease; O6 methylguanine DNA methyltransferase; Pituitary carcinoma; Temozolomide

Indexed keywords

TEMOZOLOMIDE;

ADULT; ARTICLE; CASE REPORT; CUSHING DISEASE; DRUG EFFECT; GAMMA KNIFE RADIOSURGERY; HUMAN; HYPOPHYSIS DISEASE; MALE; PITUITARY CARCINOMA; THROMBOCYTOPENIA; TUMOR GROWTH; TUMOR VOLUME;

ADENOMA; ADRENOCORTICOTROPIC HORMONE; ADULT; ANTINEOPLASTIC AGENTS, ALKYLATING; DACARBAZINE; HUMANS; MALE; PITUITARY ACTH HYPERSECRETION; PITUITARY NEOPLASMS; TREATMENT OUTCOME;

EID: 78650271374     PISSN: None     EISSN: 1537744X     Source Type: Journal    
DOI: 10.1100/tsw.2010.210     Document Type: Article

References (41)

1. Pernicone, P.J. and Scheithauer, B.W. (2001) Invasive pituitary adenoma and pituitary carcinoma. In Diagnosis and Management of Pituitary Tumors. Thapar, K., Kovacs, K., Scheithauer, B.W., et al., Eds. Humana Press, Totowa, NJ. pp. 369-386.
2. Pernicone, P.J., Scheithauer, B.W., Sebo, T.J., et al. (1997) Pituitary carcinoma: a clinicopathologic study of 15 cases. Cancer 79, 804-812.
3. Pichard, C., Gerber, S., Laloi, M., et al. (2002) Pituitary carcinoma: report of an exceptional case and review of the literature. J. Endocrinol. Invest. 25, 65-72. (Pubitemid 34168342)
4. Ragel, B.T. and Couldwell, W.T. (2004) Pituitary carcinoma: a review of the literature. Neurosurg. Focus 16, 1-9.
5. Scheithauer, B.W., Randall, R.V., Laws, E.R., Jr., Kovacs, K.T., Horvath, E., and Whitaker, M.D. (1985) Prolactin cell carcinoma of the pituitary. Clinicopathologic, immunohistochemical, and ultrastructural study of a case with cranial and extracranial metastases. Cancer 55, 598-604.
6. Scheithauer, B.W., Kurtkaya-Yapicier, O., Kovacs, K.T., Young, W.F., Jr., and Lloyd, R.V. (2005) Pituitary carcinoma: a clinicopathological review. Neurosurgery 56, 1066-1074.
7. Farrell, W.E., Coll, A.P., Clayton, R.N., and Harris, P.E. (2003) Corticotroph carcinoma presenting as a silent corticotroph adenoma. Pituitary 6, 41-47.
8. Lopes, M.B., Scheithauer, B.W., and Schiff, D. (2005) Pituitary carcinoma: diagnosis and treatment. Endocrine 28, 115-121.
9. Kovacs, K., Scheithauer, B.W., Horvath, E., and Lloyd, R.V. (1996) The World Health Organization classification of adenohypophysial neoplasms. A proposed five-tier scheme. Cancer 78, 502-510.
10. Kaltsas, G.A., Nomikos, P., Kontogeorgos, G., Buchfelder, M., and Grossman, A.B. (2005) Clinical review: diagnosis and management of pituitary carcinomas. J. Clin. Endocrinol. Metab. 90, 3089-3099. (Pubitemid 40686369)
11. Fadul, C.E., Kominsky, A.L., Meyer, L.P., et al. (2006) Long-term response of pituitary carcinoma to temozolamide. Report of two cases. J. Neurosurg. 105, 621-626.
12. Hagen, C., Schroder, H.D., Hansen, S., Hagen, C., and Andersen, M. (2009) Temozolamide treatment of a pituitary carcinoma and two pituitary macroadenomas resistant to conventional therapy. Eur. J. Endocrinol. 161, 631-637.
13. Raverot, G., Sturm, N., de Fraipont, F., et al. (2010) Temozolomide treatment in aggressive pituitary tumors and pituitary carcinomas: a French multicenter experience. J. Clin. Endocrinol. Metab. 95, 4592-4599.
14. Syro, L.V., Ortiz, L.D., Scheithauer, B.W., et al. (2010) Treatment of pituitary neoplasms with temozolomide: a review. Cancer [Epub ahead of print]
15. 6-methylguanine DNA methyltransferase expression in invasive macroadenomas of Cushing's disease. Eur. J. Endocrinol. 161, 553-559.
16. Zahedi, A., Booth, G.L., Smyth, H.S., et al. (2001) Distinct clonal composition of primary and metastatic adrenocorticotrophic hormone-producing pituitary carcinoma. Clin. Endocrinol. 55, 549-556.
17. Clayton, R.N., Pfeifer, M., Atkinson, A.B., et al. (2000) Different patterns of allelic loss (loss of heterozygosity) in recurrent human pituitary tumors provide evidence for multiclonal origins. Clin. Cancer Res. 6, 3973-3982.
18. Roncaroli, F., Scheithauer, B.W., Young, W.F., et al. (2003) Silent corticotroph carcinoma of the adenohypophysis: a report of five cases. Am. J. Surg. Pathol. 27, 477-486. (Pubitemid 36368545)
19. Atienza, D.M., Vigersky, R.J., Lack, E.E., et al. (1991) Prolactin-producing pituitary carcinoma with pulmonary metastases. Cancer 68, 1605-1610.
20. Landman, R.E., Horwith, M., Peterson, R.E., Khandji, A.G., and Wardlaw, S.L. (2002) Long-term survival with ACTH-secreting carcinoma of the pituitary: a case report and review of the literature. J. Clin. Endocrinol. Metab. 87, 3084-3089.
21. Levesque, H., Freger, P., Gancel, A., Tayot, J., and Courtois, H. (1991) Primary carcinoma of the pituitary gland with Cushing's syndrome and metastases. Apropos of a case with review of the literature. Rev. Med. Interne 12, 209-212.
22. Lormeau, B., Miossec, P., Sibony, M., Valensi, P., and Attali, J.R. (1997) Adrenocorticotropin-producing pituitary carcinoma with liver metastasis. J. Endocrinol. Invest. 20, 230-236.
23. Masuda, T., Akasaka, Y., Ishikawa, Y., et al. (1999) An ACTH-producing pituitary carcinoma developing Cushing's disease. Pathol. Res. Pract. 195, 183-187. (Pubitemid 29142217)
24. Kaltsas, G.A. and Mukherjee, J.J. (1998) The role of cytotoxic chemotherapy in the management of aggressive and malignant pituitary tumors. J. Clin. Endocrinol. Metab. 83, 4233-4238.
25. Kaltsas, G.A. and Grossman, A.B. (1998) Malignant pituitary tumours. Pituitary 1, 69-81.
26. van der Klaauw, A.A., Kienitz, T., Strasburger, C.J., Smit, J.W., and Romijn, J.A. (2009) Malignant pituitary corticotroph adenomas: report of two cases and a comprehensive review of the literature. Pituitary 12, 57-69.
27. Glantz, M., Chamberlain, M., Liu, Q., Litofsky, N.S., and Recht, L.D. (2003) Temozolomide as an alternative to irradiation for elderly patients with newly diagnosed malignant gliomas. Cancer 97, 2262-2266.
28. Stupp, R., Dietrich, P.Y., Ostermann Kraljevic, S., et al. (2002) Promising survival for patients with newly diagnosed glioblastoma multiforme treated with concomitant radiation plus temozolomide followed by adjuvant temozolomide. J. Clin. Oncol. 20, 1375-1382.
29. Stupp, R. and Newlands, E. (2001) New approaches for temozolomide therapy: use in newly diagnosed glioma. Semin. Oncol. 28, 19-23. (Pubitemid 32879942)
30. Zhu, Y., Shahinian, H., Hakimian, B., Bonert, V., Lim, S., and Heaney, A. (2004). Temodar: novel treatment for pituitary carcinoma. US Endocr. Soc. 138, 43-45.
31. Lim, S., Shahinian, H., Maya, M.M., Yong, W., and Heaney, A.P. (2006) Temozolomide: a novel treatment for pituitary carcinoma. Lancet 7, 518-520.
32. 6-methylguanine-DNA methyltransferase (MGMT) expression and response to temozolomide in aggressive pituitary tumours. Clin. Endocrinol. 71, 226-233.
33. Byrne, S., Karapetis, C., and Vrodos, N. (2009) A novel use of temozolomide in a patient with malignant prolactinoma. J. Clin. Neurosci. 16, 1694-1696.
34. Mohammed, S., Kovacs, K., Mason, W., Smyth, H., and Cusimano, M.D. (2009) Use of temozolamide in aggressive pituitary tumors: case report. Neurosurgery 64, E773-E774.
35. Thearle, M., Freda, P., Bruce, J., Isaacson, S., Lee, Y., and Fine, R. (2009) Temozolomide (Temodar®) and capecitabine (Xeloda®) treatment of an aggressive corticotroph pituitary tumor. Pituitary [Epub ahead of print]
36. Neff, L.M., Weil, M., Cole, A., et al. (2007) Temozolomide in the treatment of an invasive prolactinoma resistant to dopamine agonists. Pituitary 10, 81-86.
37. Kovacs, K., Horvath, E., Syro, L.V., et al. (2007) Temozolomide therapy in a man with an aggressive prolactinsecreting pituitary neoplasm: morphological findings. Hum. Pathol. 38, 185-189.
38. Syro, L.V., Uribe, H., Penagos, L.C., et al. (2006) Antitumour effects of temozolomide in a man with a large, invasive prolactin-producing pituitary neoplasm. Clin. Endocrinol. 65, 552-553.
39. Moyes, V.J., Alusi, G., Sabin, H.I., et al. (2009) Treatment of Nelson's syndrome with temozolomide. Eur. J. Endocrinol. 160, 115-119.
40. Bush, Z.M., Longtine, J.A., Cunningham, T., et al. (2010) Temozolomide treatment for aggressive pituitary tumors: correlation of clinical outcome with O6-methylguanine methyltransferase (MGMT) promoter methylation and expression. J. Clin. Endocrinol. Metab. [Epub ahead of print]
41. Kovacs, K., Scheithauer, B.W., Lombardero, M., et al. (2008) MGMT immunoexpression predicts responsiveness of pituitary tumors to temozolomide therapy. Acta Neuropathol. 115, 261-262.